为您找到相关结果约500个

你是不是要搜索 期刊骨髓增生异常综合征修订国际预后积分系统（IPSS-R） 点击跳转

Prognosis of patients with intermediate risk IPSS-R myelodysplastic syndrome indicates variable outcomesand need for models beyond IPSS-R

IPSS-M has greater survival predictive accuracy compared with IPSS-R in persons >= 60 years with myelodysplastic

The IPSS-R more accurately captures fatigue severity of newly diagnosed patients with myelodysplasticsyndromes compared with the IPSS index

Response to Erythropoiesis-Stimulating Agent Therapy in IPSS-R Lower Risk Myelodysplastic Syndrome PatientsRestratified According to IPSS-M

The IPSS-R has prognostic impact in untreated patients with MDS del(5q)

Comparison of Molecular International Prognostic Scoring System (M-IPSS) and Revised International PrognosticScoring System (R-IPSS) in Thai patients with myelodysplastic neoplasms

Prognostic evaluation of ALIP and CD34 immunostaining in IPSS-R subgroups of myelodysplastic syndromes

IPSS-M Predicts Survival Outcomes Significantly Better Than IPSS-R in Patients Undergoing Allogeneic

next-generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS-R

PATIENTS WITH IPSS-R INTERMEDIATE RISK CAN BE SEPARATED INTO THREE RISK GROUPS

COMPARISON OF PROGNOSTICATION BY IPSS-M, IPSS-R AND AIPSS-MDS IN THE CONTEXT OF LIMITED AVAILABILITY

R-IPSS STRATIFICATION AND SURVIVAL AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MYELODYSPLASTIC SYNDROME

Refined cytogenetic IPSS-R evaluation by the use of SNP array in a cohort of 290 MDS patients

Molecular Data and the IPSS-R: How Mutational Burden Can Affect Prognostication in MDS

Absolute Monocyte Count at Diagnosis Affects Prognosis in Myelodysplastic Syndromes Independently of the IPSS-R

为您找到相关结果约500个

共500条页码: 1/34页15条/页